Insulin resistance and hyperinsulinemia

Diabetes Care

Volumn 31, Issue 7, 2008, Pages 1433-1438

  Kim, Sun H ^a   Reaven, Gerald M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR; GLUCOSE TOLERANCE TEST; HYPERINSULINISM; MIDDLE AGED; REFERENCE VALUE;

ADULT; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERINSULINISM; INSULIN RESISTANCE; MALE; MIDDLE AGED; REFERENCE VALUES; RISK FACTORS;

EID: 49649083576     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-0045     Document Type: Article

References (27)

1. Reaven GM, Olefsky JM: Relationship between heterogeneity of insulin responses and insulin resistance in normal subjects and patients with chemical diabetes. Dia- betologia 13:201-206, 1977
2. Hollenbeck C, Reaven GM: Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab 64: 1169-1173, 1987
3. Reaven GM: Banting Lecture 1988: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
4. Kim SH, Abbasi F, Reaven GM: Impact of degree of obesity on surrogate estimates of insulin resistance. Diabetes Care 27: 1998-2002, 2004
5. Welborn TA, Breckenridge A, Rubinstein AH, Dollery CT, Fraser TR: Serum-insulin in essential hypertension and in peripheral vascular disease. Lancet 1:13361337, 1966
6. Pyorala K: Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabe- tes Care 2:131-141, 1979
7. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH: Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes. Lancet 1:1356-1359, 1989
8. Despres JP, Lamarche B, Mauriege P, Can- tin B, Dagenais GR, Moorjani S, Lupien PJ:
9. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334:952-957, 1996
10. Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, Karim R, Lin R, Samarasinghe D, Liddle C, Welt- man M, George J: NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 35:373-379, 2002
11. Dunaif A, Segal KR, Futterweit W, Do- brjansky A: Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38: 1165-1174, 1989
12. Lind L, Lithell H, Pollare T: Is it hyperin- sulinemia or insulin resistance that is related to hypertension and other metabolic cardiovascular risk factors? J Hypertens 11 (Suppl.):S11-S16, 1993
13. Weyer C, Hanson RL, Tataranni PA, Bo- gardus C, Pratley RE: A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia. Diabetes 49: 2094 -2101, 2000
14. Ferrannini E, Balkau B: Insulin: in search of a syndrome. Diabet Med 19:724 -729, 2002
15. Ferrannini E, Balkau B, Coppack SW, Dekker JM, Mari A, Nolan J, Walker M, Natali A, Beck-Nielsen H: Insulin resistance, insulin response, and obesity as indicators of metabolic risk. J Clin Endocrinol Metab 92:2885-2892, 2007
16. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
17. Yeni-Komshian H, Carantoni M, Abbasi F, Reaven GM: Relationship between several surrogate estimates of insulin resistance and quantification of insulin- mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care 23: 171-175, 2000
18. Pei D, Jones CN, Bhargava R, Chen YD, Reaven GM: Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test. Diabetolo- gia 37:843-845, 1994
19. Shen SW, Reaven GM, Farquhar JW: Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. JClin Invest 49:2151-2160, 1970
20. Greenfield MS, Doberne L, Kraemer F, Tobey T, Reaven G: Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp. Diabetes 30:387-392, 1981
21. Olefsky JM, Reaven GM: Insulin and glucose responses to identical oral glucose tolerance tests performed forty-eight hours apart. Diabetes 23:449 -453, 1974
22. Elahi D, Nagulesparan M, Hershcopf RJ, Muller DC, Tobin JD, Blix PM, Ruben- stein AH, Unger RH, Andres R: Feedback inhibition of insulin secretion by insulin: relation to the hyperinsulinemia of obesity. NEngl J Med 306:1196-1202, 1982
23. Bonora E, Zavaroni I, Bruschi F, Alpi O, Pezzarossa A, Guerra L, Dall'Aglio E, Cos- celli C, Butturini U: Peripheral hyperinsu- linemia of simple obesity: pancreatic hypersecretion or impaired insulin me-tabolism? J Clin Endocrinol Metab 59: 1121-1127, 1984
24. Polonsky KS, Given BD, Hirsch L, Shapiro ET, Tillil H, Beebe C, Galloway JA, Frank BH, Karrison T, Van Cauter E: Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest 81:435-441, 1988
25. Jones CN, Abbasi F, Carantoni M, Polon- sky KS, Reaven GM: Roles of insulin resistance and obesity in regulation of plasma insulin concentrations. Am J Physiol 278:E501-E508, 2000
26. Meistas MT, Margolis S, Kowarski AA: Hyperinsulinemia of obesity is due to decreased clearance of insulin. Am JPhysiol 245:E155-E159, 1983
27. Reaven GM: The insulin resistance syndrome. Curr Atheroscler Rep 5:364-371, 2003